A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions
Crossref DOI link: https://doi.org/10.1007/s13555-018-0252-3
Published Online: 2018-07-27
Published Print: 2018-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
De Padova, Maria Pia
Marzani, Barbara
Pinto, Daniela
Rinaldi, Fabio
Funding for this research was provided by:
Giulini SpA
Article History
Received: 20 June 2018
First Online: 27 July 2018